Delivery Order SPE2DB22D2006-SPE2DB23FW1JF
Award Date 7/20/23
Potential Completion Date 7/21/23
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $7,664.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561365617 HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The order is to be performed by Amerisourcebergen's Conshohocken, Pennsylvania facility by June 29, 2023 under the parent company Amerisourcebergen Corporation's corporate office division contract vehicle. No subcontractors or set aside designations were indicated. The Defense Logistics Agency functions include procuring...
- The Defense Logistics Agency awarded a $37,860.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561593662 HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on July 25, 2023 through July 26, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the U.S. Department of Defense, this delivery...
- The Defense Logistics Agency awarded a $95,802.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561537036 HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for the delivery of HEPLISAV-B vaccine syringes and has a period of performance from July 17, 2023 through July 18, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the United States...
- The Defense Logistics Agency awarded a $7,664.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562047436 HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance spanning September 5-6, 2023. No set aside designation or subcontracting details were provided. The Defense Logistics Agency manages the global supply chain for the...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $3,066 to Amerisourcebergen Drug Corporation for 4561607454 HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The contract has a period of performance from July 26-27, 2023 at Amerisourcebergen's place of performance in Conshohocken, Pennsylvania. As the DLA supports the Department of Defense by providing supplies and services to America's armed forces, this delivery order was likely placed under the DLA's...
- The Defense Logistics Agency awarded a $9,632 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for 4562127036 HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The prime contractor, Amerisourcebergen Drug Corporation located in Conshohocken, Pennsylvania, will provide the specified vaccines to the Defense Logistics Agency between September 11-12, 2023. No major subcontractors or set aside designations were indicated. This delivery order is likely in support of the Defense...
- The Defense Logistics Agency Troop Support Medical awarded a $3,385 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561909721 HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. This delivery order was issued against an unspecified indefinite-delivery/indefinite-quantity contract vehicle and requires the prime contractor, Amerisourcebergen, to provide the specified hepatitis B...
- The Defense Logistics Agency awarded a $766 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562180733 HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The order is associated with DLA's pharmaceutical supply chain support for the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over one day in September 2023. No set aside designation or subcontractors are indicated. This order supports DOD's vaccine distribution programs by providing a hepatitis...
- The Defense Logistics Agency awarded a $38,321 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561674277 HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services in support of DLA missions. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all items to be delivered by August 1, 2023. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $2,644.06 firm fixed price delivery order to Amerisourcebergen Drug Corporation for HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The order period of performance is July 18-19, 2023. No set aside designation or subcontractors are indicated. The Defense Logistics Agency manages the Department of Defense's global logistics network, and this order for hepatitis B...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB23FW1JFDelivery Order
The Defense Logistics Agency awarded a $19,160.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561557895 HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. Funding is provided by the Defense Logistics Agency to support its medical product procurement and distribution activities. No subcontractors or set aside designations were identified. This order is likely part of DLA's stocking and distribution of FDA-approved vaccines and related supplies for United States military and public health purposes.
Generated 12/16/23, 5:38 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.2k | 7/20/23 |